Health
Host tissue T cells may have an unexpected role in graft-versus-host disease – Medical Xpress
Allogenic hematopoietic stem cell transplantation (HSCT) is a procedure that infuses a donor’s healthy blood-forming stem cells into a recipient as part of a potentially curative therapy for cancer. While this therapy can be life-saving, a major complication …
Allogenic hematopoietic stem cell transplantation (HSCT) is a procedure that infuses a donor’s healthy blood-forming stem cells into a recipient as part of a potentially curative therapy for cancer. While this therapy can be life-saving, a major complication is the development of graft-versus-host disease (GVHD), which causes significant morbidity and can be fatal. Before allogenic HSCT, a patient receives a conditioning regimen, chemotherapy designed to deplete his/her normal white blood cells,…
-
Noosa News24 hours agoThe only person detained at Brisbane’s Palestine rally
-
Noosa News21 hours agoQueensland government to introduced artificial intelligence teaching tool Corella to all state high schools
-
Business23 hours agoHow to turn $500 a month into $500,000 with ASX shares
-
General16 hours agoAustralia urged to give AUKUS sub ‘commitments’ to US in event of war